Recursion Pharmaceuticals (NasdaqGS:RXRX) Q1 2026 Earnings call May 06, 2026 08:00 AM ET Company ParticipantsBen Taylor - CFONajat Khan - CEO and PresidentVicki Goodman - Chief Medical OfficerNajat KhanGood morning, everyone, and thank you for joining us. Since stepping into this role, I've been focused on a singular question. How do we harness the full power of AI to consistently and with urgency create better medicines for patients? That requires bold ambition and a lot of focus and discipline to create v ...